Your browser doesn't support javascript.
loading
TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line.
Baranasic, Jurica; Sutic, Maja; Catalano, Calogerina; Drpa, Gordana; Huhn, Stefanie; Majhen, Dragomira; Nestic, Davor; Kurtovic, Matea; Rumora, Lada; Bosnar, Martina; Vukic Dugac, Andrea; Sokolovic, Irena; Popovic-Grle, Sanja; Orsolic, Nada; Skrinjaric-Cincar, Sanda; Jakopovic, Marko; Samarzija, Miroslav; Weber, Alexander N R; Försti, Asta; Knezevic, Jelena.
Afiliação
  • Baranasic J; Laboratory for Advanced Genomics, Division of Molecular Medicine, Ruder Boskovic Institute, Bijenicka Cesta 54, 10000 Zagreb, Croatia.
  • Sutic M; Laboratory for Advanced Genomics, Division of Molecular Medicine, Ruder Boskovic Institute, Bijenicka Cesta 54, 10000 Zagreb, Croatia.
  • Catalano C; Division of Molecular Genetic Epidemiology, DKFZ, 69120 Heidelberg, Germany.
  • Drpa G; Clinical Department for Respiratory Diseases Jordanovac, School of Medicine, University Hospital Centre Zagreb, University of Zagreb, 10000 Zagreb, Croatia.
  • Huhn S; Division of Molecular Genetic Epidemiology, DKFZ, 69120 Heidelberg, Germany.
  • Majhen D; Department of Internal Medicine V, Heidelberg University Hospital, University of Heidelberg, 69120 Heidelberg, Germany.
  • Nestic D; Laboratory for Cell Biology and Signaling, Division of Molecular Biology, Ruder Boskovic Institute, 10000 Zagreb, Croatia.
  • Kurtovic M; Laboratory for Cell Biology and Signaling, Division of Molecular Biology, Ruder Boskovic Institute, 10000 Zagreb, Croatia.
  • Rumora L; Laboratory for Advanced Genomics, Division of Molecular Medicine, Ruder Boskovic Institute, Bijenicka Cesta 54, 10000 Zagreb, Croatia.
  • Bosnar M; Department of Medical Biochemistry and Hematology, Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia.
  • Vukic Dugac A; Fidelta d.o.o., Prilaz Baruna Filipovica 29, 10000 Zagreb, Croatia.
  • Sokolovic I; Clinical Department for Respiratory Diseases Jordanovac, School of Medicine, University Hospital Centre Zagreb, University of Zagreb, 10000 Zagreb, Croatia.
  • Popovic-Grle S; Clinical Department for Respiratory Diseases Jordanovac, School of Medicine, University Hospital Centre Zagreb, University of Zagreb, 10000 Zagreb, Croatia.
  • Orsolic N; Clinical Department for Respiratory Diseases Jordanovac, School of Medicine, University Hospital Centre Zagreb, University of Zagreb, 10000 Zagreb, Croatia.
  • Skrinjaric-Cincar S; Faculty of Science, Department of Biology, University of Zagreb, 10000 Zagreb, Croatia.
  • Jakopovic M; Faculty of Medicine, J.J. Strossmayer University of Osijek, 31000 Osijek, Croatia.
  • Samarzija M; Clinical Department for Respiratory Diseases Jordanovac, School of Medicine, University Hospital Centre Zagreb, University of Zagreb, 10000 Zagreb, Croatia.
  • Weber ANR; Clinical Department for Respiratory Diseases Jordanovac, School of Medicine, University Hospital Centre Zagreb, University of Zagreb, 10000 Zagreb, Croatia.
  • Försti A; Department of Immunology, University of Tübingen, 72074 Tübingen, Germany.
  • Knezevic J; iFIT-Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University Hospital Tübingen-Internal Medicine VIII, 72076 Tübingen, Germany.
Biomedicines ; 10(9)2022 Sep 09.
Article em En | MEDLINE | ID: mdl-36140341
ABSTRACT
Chronic obstructive pulmonary disease (COPD) is considered as the strongest independent risk factor for lung cancer (LC) development, suggesting an overlapping genetic background in both diseases. A common feature of both diseases is aberrant immunity in respiratory epithelia that is mainly regulated by Toll-like receptors (TLRs), key regulators of innate immunity. The function of the flagellin-sensing TLR5 in airway epithelia and pathophysiology of COPD and LC has remained elusive. We performed case−control genetic association and functional studies on the importance of TLR5 in COPD and LC development, comparing Caucasian COPD/LC patients (n = 974) and healthy donors (n = 1283). Association analysis of three single nucleotide polymorphisms (SNPs) (rs725084, rs2072493_N592S, and rs5744174_F616L) indicated the minor allele of rs2072493_N592S to be associated with increased risk for COPD (OR = 4.41, p < 0.0001) and NSCLC (OR = 5.17, p < 0.0001) development and non-small cell LC risk in the presence of COPD (OR = 1.75, p = 0.0031). The presence of minor alleles (rs5744174 and rs725084) in a co-dominant model was associated with overall survival in squamous cell LC patients. Functional analysis indicated that overexpression of the rs2072493_N592S allele affected the activation of NF-κB and AP-1, which could be attributed to impaired phosphorylation of p38 and ERK. Overexpression of TLR5N592S was associated with increased chemosensitivity in the H1299 cell line. Finally, genome-wide transcriptomic analysis on WI-38 and H1299 cells overexpressing TLR5WT or TLR5N592S, respectively, indicated the existence of different transcription profiles affecting several cellular pathways potentially associated with a dysregulated immune response. Our results suggest that TLR5 could be recognized as a potential biomarker for COPD and LC development with functional relevance.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article